PPT-New non-injectable naloxone products: Global overview

Rebecca McDonald National Addiction Centre Kings College London Declarations RM has undertaken an unpaid student industry placement with Mundipharma Research Ltd with focus on the analysis of naloxone nasal spray formulations. Emergency Medical Responders and. Law Enforcement. There may be a title here that come from the foundation. Objectives . In this slide set, you will learn:. What naloxone (. Narcan. ) is. How it works when administered to a person who has overdosed. John J. Faragon, Pharmacist, HIV Medicine. Regional Pharmacy Director, . NY/NJ AIDS Education and Training Center. Objectives. Describe the correlation between prescription drug abuse and the rate of opioid related overdose deaths. . Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf of the HPTN-076 Team. UZ-UCSF Annual Research Day. May 05, 2017 Harare. Background. Introduction to . Rilpivirine. (TMC 278). HPTN-076. Study Design. Public Concern. Public Expectation. “All the Other Kids Are Doing It”. 256.40(3)(b). Opioid. Antagonists. A law enforcement officer or fire fighter who, reasonably believing another person to be undergoing an . Catherine Borella Chemistry BA Class of 2016. Senior Chemistry Seminar . University of New Hampshire, Durham, NH, USA. Discussions. How the Government is Mandating Naloxone. Monte-Carlo (MC) Simulation Approach . Los Angeles County EMS Agency. Special Thanks for the Development of this Program. UCLA Center for Prehospital Care. Los Angeles EMS Agency Curriculum Committee. This . training . program. meets the regulatory . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . accidental death in America . . Please read the consent agreement in front of you and further instructions will be given on how to complete the pre-training survey. . . Remove . the “ID” number label and save it . – you’ll need this for today’s post-training survey, . Findings from a linked dataset. Dan Galanis, Ph.D.. Epidemiologist. EMS & Injury Prevention System Branch. Hawaii Department of Health. 2. Overview of presentation. Part 1: EMS administration of naloxone (2012-2016). First Responder Naloxone Grant FY18 Webinar Sarah Ruiz, Program Director Dr. Alex Walley, Medical Director Brittni Reilly, Program Coordinator Monday 9/25/2017 Audio:   1-877-838-7060 Agenda Review of Current Statistics / Trends Goals Of Training. Indiana Recovery Alliance. Identify and Prevent Opiate Overdoses. What is Naloxone. How To Administer Naloxone . Practice Administering Naloxone. Review. So What Is The IRA ?. WHAT IS THE IRA?. Community Placement of Lifesaving Equipment. Naloxone. Overdose antidote. Administered via injection or nasal aerosol. Onset of action 3-15 . mins. Duration of action: 30-45 . mins. Image courtesy of Prescribe to Prevent. NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and . Presented by Carol Nati MD, MS, DFAPA. Medical Director, MHMR of Tarrant County. Overview. Long Acting Injectable Antipsychotic Medications are underutilized in Texas.. They have been proven to work well..